Dong-A Socio Holdings Co., Ltd.

Equities

A000640

KR7000640003

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
112,300 KRW -1.49% Intraday chart for Dong-A Socio Holdings Co., Ltd. -1.66% +11.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Dong-A ST Sets Sight on European Market with Stelara Biosimilar Expansion MT
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dong-A Socio Holdings Co., Ltd's Equity Buyback announced on October 26, 2022, has expired. CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Dong-A Socio Holdings Co., Ltd. announces an Equity Buyback for 50,301 shares. CI
Dong-A Socio Holdings Co., Ltd. authorizes a Buyback Plan. CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Dong-A Socio Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Dong-A Socio Holdings Co., Ltd. agreed to acquire an additional 29.4% stake in DM Bio, Ltd. from Meiji Seika Pharma Co., Ltd for KRW 42.1 billion. CI
Dong-A Socio Holdings Co., Ltd.(KOSE:A000640) dropped from KOSPI 200 Index CI
Tranche Update on Dong-A Socio Holdings Co., Ltd.'s Equity Buyback Plan announced on March 20, 2020. CI
Tranche Update on Dong-A Socio Holdings Co., Ltd.'s Equity Buyback Plan announced on March 20, 2020. CI
Dong-A Socio Holdings Co., Ltd.'s Equity Buyback announced on March 20, 2020, has expired with 98,190 shares, representing 1.61% for KRW 8,384.55 million. CI
Dong-A Socio Holdings Co., Ltd. announces an Equity Buyback for 140,000 shares. CI
Dong-a Pharmaceutical Co. Ltd. authorizes a Buyback Plan. CI
Meiji Seika Pharma Co., Ltd. and Dong-A Socio Holdings Co., Ltd. Announces the Initiation of A Phase I Clinical Trial of Dmb-3115 CI
INTAKE Co., Ltd. announced that it has received KRW 3.8 billion in funding from Dong-A Socio Holdings Co., Ltd., SOFTBANK Ventures Korea Inc. CI
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of an additional stake in ST Pharm Co. Ltd.. CI
Dong-A Socio Holdings Co. Ltd. cancelled the acquisition of additional 10% stake in ST Pharm Co. Ltd. from Dong-A ST Co., Ltd.. CI
Dong-A Socio Holdings Co. Ltd. cancelled the sale of 49% stake in DMB Limited. CI
Chart Dong-A Socio Holdings Co., Ltd.
More charts
Dong-A Socio Holdings Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through five segments. The Medicine Manufacturing segment is engaged in the manufacture and sale of pharmaceuticals. The main pharmaceuticals include tonic medicines, cold medicines, raw material medicines. The Logistic segment is involved in the freight, courier, car transportation, freight warehousing and leasing business. The Packaging segment is engaged in manufacturing and sale of glass and glass products. The Holding Company segment is engaged in the provision of core companies and management consulting services. The Other segment is engaged in the production and sale of information and communication technology (IT) solutions and agricultural products, as well as real estate development business.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
112,300 KRW
Average target price
155,000 KRW
Spread / Average Target
+38.02%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A000640 Stock
  4. News Dong-A Socio Holdings Co., Ltd.
  5. Dong-A ST Sets Sight on European Market with Stelara Biosimilar Expansion